ScholarIQanswers from OpenAlex & ORCID
Andreas Schober
ResearcherPublications, citations & collaboration network
Andreas Schober is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Andreas Schober have?
ScholarIQindexed works
Andreas Schober has 279 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Andreas Schober have?
ScholarIQcitation count
Andreas Schober has 17,757 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Andreas Schober?
ScholarIQh-index
Andreas Schober has an h-index of 69 in OpenAlex.
What is the i10-index of Andreas Schober?
ScholarIQi10-index
Andreas Schober has an i10-index of 150 in OpenAlex.
What is the ORCID of Andreas Schober?
ScholarIQorcid
The ORCID for Andreas Schober is on the source record.
What is the OpenAlex record for Andreas Schober?
ScholarIQopenalex
The OpenAlex for Andreas Schober is on the source record.
What are the most-cited papers on Andreas Schober?
ScholarIQmost cited works
Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E
Yuqing Huo, Andreas Schober, S. Bradley Forlow, David F. Smith, Matthew C. Hyman, Steffen Jung, Dan R. Littman, Christian Weber, Klaus Ley
MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1
Andreas Schober, Maliheh Nazari-Jahantigh, Yuanyuan Wei, Kiril Bidzhekov, Felix Gremse, Jochen Grommes, Remco T. A. Megens, Kathrin Heyll, Heidi Noels, Michael Hristov, Shusheng Wang, Fabian Kießling, Eric N. Olson, Christian Weber
MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages
Maliheh Nazari-Jahantigh, Yuanyuan Wei, Heidi Noels, Shamima Akhtar, Zhe Zhou, Rory R. Koenen, Kathrin Heyll, Felix Gremse, Fabian Kießling, Jochen Grommes, Christian Weber, Andreas Schober
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly, Keith A.A. Fox, Jonas Oldgren, W. Schuyler Jones, Diana A. Gorog, Václav Durdil, Thomas Viethen, Christoph Neumann, Hardi Mundl, Manesh R. Patel, Johann Auer, Martin Hubauer, Sead Pandzic, Eva Preishuber, Carina Primus-Grabscheit, Dietmar Reitgruber, Florian Schmalzer, Christopher Adlbrecht, Andreas Schober, Johannes Hajos, Christoph Keil, Alexandra Schratter, Matthias Frick, Magdalena Benda, Maximilian Mächler, Beatrix Mutschlechner, Christoph H. Saely, Lukas Sprenger, Michael Lichtenauer, Miriam Eber, Uta C. Hoppe, Tobias Kolbitsch, Peter Jirak, Moritz Mirna, Robert Schönbauer, Jutta Bergler‐Klein, Christian Hengstenberg, Stefan Stojković, Daniel Scherr, Martin Manninger-Wünscher, Ursula Rohrer, Markus Stühlinger, Wilfried Schgoer, Jana M. Schwarzl, Helmut Pürerfellner, Michael Derndorfer, Christian Ebner, Veronika Eder, Γεώργιος Κόλλιας, Thomas Sturmberger, Stefan Sieghartsleitner, Johan Vijgen, Peter Koopman, Karl Dujardin, Wim Anné, Michel De Ceuninck, René Tavernier, Mattias Duytschaever, Sébastien Knecht, Luc Missault, Yves Vandekerckhove, Tom Rossenbacker, Bavo Ector, Filip Charlier, Philippe Debruyne, Willem Dewilde, Luc Janssens, John Roosen, Bart Vankelecom, Hein Heidbüchel, Michiel Delesie, G. M. M. Vervoort, Hans Rombouts, Thomas Vanassche, Matthias M. Engelen, Peter Verhamme, Rik Willems, Christian Constance, Nicolas Pranno, Jafna L. Cox, Iqbal Bata, Laurent Macle, Martín Aguilar, J. Tourigny, Marc Dubuc, Katia Dyrda, Peter G. Guerra, Paul Khairy, Blandine Mondésert, Léna Rivard, Denis Roy, Rafik Tadros, Mario Talajic, Bernard Thibault, Isabelle Nault, L. Blier, Jean Champagne, Franck Molin
Correction: Corrigendum: Endothelial Dicer promotes atherosclerosis and vascular inflammation by miRNA-103-mediated suppression of KLF4
Petra Hartmann, Zhe Zhou, Lucia Natarelli, Yuanyuan Wei, Maliheh Nazari-Jahantigh, Mengyu Zhu, Jochen Grommes, Sabine Steffens, Christian Weber, Andreas Schober